WallStreetZenWallStreetZen

NASDAQ: CGEM
Cullinan Therapeutics Inc Stock Ownership - Who owns Cullinan Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cullinan Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer MichaelsonChief Scientific Officer2026-07-064,000$4.30
$17.20kBuy
Jennifer MichaelsonChief Scientific Officer2026-07-068,000$17.82
$142.56kSell
Mary Kay FentonChief Financial Officer2026-06-301,541$8.60
$13.25kBuy
Jacquelyn L. SumerChief Legal Officer2026-06-302,470$8.60
$21.24kBuy
Jennifer MichaelsonChief Scientific Officer2026-05-054,000$4.30
$17.20kBuy
Jennifer MichaelsonChief Scientific Officer2026-05-05200$15.58
$3.12kSell
Jennifer MichaelsonChief Scientific Officer2026-05-057,800$14.60
$113.88kSell
Jennifer MichaelsonChief Scientific Officer2026-03-054,000$4.30
$17.20kBuy
Jennifer MichaelsonChief Scientific Officer2026-03-058,000$15.68
$125.44kSell
Jennifer MichaelsonChief Scientific Officer2026-02-251,780$14.14
$25.17kSell

1 of 5

CGEM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGEM insiders and whales buy or sell their stock.

CGEM Shareholders

What type of owners hold Cullinan Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ansbert Gadicke26.29%16,157,644$285.83MInsider
Lynx1 Capital Management LP14.58%8,963,500$158.56MInsider
Lynx1 Capital Management LP14.58%8,963,500$158.56MInstitution
Mpm Bioimpact LLC12.44%7,648,268$135.30MInstitution
Ubs Oncology Impact Fund LP12.44%7,648,268$135.30MInsider
Bvf Inc9.36%5,750,683$101.73MInstitution
Morana Jovanembiricos7.54%4,631,022$81.92MInsider
Vision Scs F27.28%4,476,350$79.19MInsider
Blackrock Inc7.24%4,449,966$78.72MInstitution
F2 Bioscience I 2017 Ltd7.21%4,430,964$78.38MInsider

1 of 3

CGEM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGEM57.24%42.76%Net BuyingNet Selling
ORIC84.79%15.21%Net SellingNet Selling
LXRX21.87%78.13%Net Buying
EYPT30.39%69.61%Net SellingNet Selling
SPTX0.00%74.84%Net BuyingNet Buying
View Top Biotech Stocks

Cullinan Therapeutics Stock Ownership FAQ

Who owns Cullinan Therapeutics?

Cullinan Therapeutics (NASDAQ: CGEM) is owned by 106.67% institutional shareholders, 79.70% Cullinan Therapeutics insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Cullinan Therapeutics shareholder, owning 16.16M shares representing 26.29% of the company. Ansbert Gadicke's Cullinan Therapeutics shares are currently valued at $285.83M.

If you're new to stock investing, here's how to buy Cullinan Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.